
CellTrans
Chicago, IL, United States celltransinc.com From their website, Nov 2026
- GMP
Work here? Claim this listing
About
CellTrans develops and manufactures cellular therapies and bioengineered technologies for diabetes and other endocrine disorders. It provides clinical islet isolation and transplantation services, pre-clinical transplant research, and in-vitro islet assay services. The company operates from Chicago, Illinois, with a research lab and a cell isolation facility at University Hospital.
Services
Clinical Services
Manufactures high-quality human islets for clinical transplantation, including FDA-approved Lantidra (donislecel-jujn) and autologous islet transplants.
Pre-Clinical Services
Provides contract research from proof of concept through IND/IDE-enabling pre-clinical testing for islets and islet-like biologics.
In-Vitro Services
Performs in vitro islet assays and microfluidic assessments to evaluate islet physiology, viability, purity, and function.
Consultations
Offers consultation services through the company contact and staff listed on the site.
Capabilities
- Assays and studies
- Rodent models
- Non-human primate
- Cell therapy
- In vivo
- Multiparametric Microfluidic Assay
- Microfluidic Oxygen Consumption Rate In Response To Glucose
8 more
- Morphology Assessment with Islet Scoring
- Viability Assessment
- Purity Assessment
- Static Glucose Stimulated Insulin Secretion (GSIS) Assay
- Identity
- Endotoxin Quantification
- Potency
- Sterility
- Scale and capacity
- Fully Certified ISO 7 and ISO 5 processing areas
- Over 1,000 sq. ft of support space
- Three rooms of ISO 14644 classified space covering 800 sq. ft.
- 1,050 sq. ft. of support space
- Two quality control laboratories
- Therapeutic areas
- Diabetes
- Type 1 diabetes
- Chronic pancreatitis
- Endocrine disorders
Instruments and platforms
- Bac-T/ALERT 3D Microbial Detection System
- Insulin ELISA
Modalities and species
- Modalities
- Cell therapy
- Species and models
- Human
- Xeno
- Rodent
- Non-human primate
- Macaques
- Immune-competent mice
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Scope: manufacture of human pancreatic islet cells (LANTIDRA)
Details
- Type
- CRO
- Founded
- 2009
- Ownership
- Small business, as registered with SAM.gov or stated on their site
- Address
- 2201 W. Campbell Park Dr. Chicago, IL 60612
Public records
- FDA drug establishment registration
- 3019202665 · API MANUFACTURE source